Angiodynamics (ANGO) Total Current Liabilities (2011 - 2026)

Angiodynamics' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $74.7 million for Q2 2026.

• Quarterly Total Current Liabilities fell 1.94% year-over-year to $74.7 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $74.7 million (down 1.94% YoY) and the FY2026 annual result came in at $74.7 million, down 1.94% from the prior year.
• Total Current Liabilities was $74.7 million for Q2 2026 at Angiodynamics, up from $66.1 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $91.2 million in Q2 2024 and bottomed at $49.4 million in Q1 2022.
• A 5-year average of $73.9 million and a median of $74.5 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 41.05% — and 2025, when it dropped 18.77%.
• Angiodynamics' Total Current Liabilities stood at $73.6 million in 2022, then grew by 6.08% to $78.0 million in 2023, then increased by 13.53% to $88.6 million in 2024, then slipped by 18.77% to $72.0 million in 2025, then gained by 3.83% to $74.7 million in 2026.
• Business Quant data shows ANGO's Total Current Liabilities at $74.7 million in Q2 2026, $66.1 million in Q1 2026, and $72.0 million in Q4 2025.